Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination

NF Smith, WD Figg, A Sparreboom - Expert opinion on drug …, 2005 - Taylor & Francis
… mediated cerivastatin transport by cyclosporin, rather than inhibition of its cytochrome P450
(CYP)… enzymes and transporters may occur to a lesser extent in individuals who carry these. …

Clinical importance of OATP1B1 and OATP1B3 in drug–drug interactions

Y Shitara - Drug metabolism and pharmacokinetics, 2011 - jstage.jst.go.jp
… aware of DDIs caused by the inhibition of these transporters. … acts as an inducer of metabolic
enzymes and transporters.Lau et al. … is not metabolized by cytochrome P450. Thus, these …

Impact of OATP transporters on pharmacokinetics

A Kalliokoski, M Niemi - British journal of pharmacology, 2009 - Wiley Online Library
… Of the 11 human OATP transporters, OATP1B1, OATP1B3 and OATP2B1 are expressed on
the … of other drug transporters and often subject to metabolism by CYP enzymes (Smith et al., …

Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter

NM Pakkir Maideen, G Manavalan… - Therapeutic …, 2018 - journals.sagepub.com
cytochrome P450 (CYP) enzymes and organic anion transporting polypeptide 1B1 (OATP1B1
transporter) … of meglitinides involving CYP enzymes and OATP1B1 transporter. To prevent …

Organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 as important regulators of the pharmacokinetics of substrate drugs

K Maeda - Biological and Pharmaceutical Bulletin, 2015 - jstage.jst.go.jp
… of hepatic uptake transporters like OATP1B1 and OATP1B3 (… of metabolic enzymes and
uptake transporters on the hepatic … these drugs should inhibit these CYP enzymes at that time. …

Understanding the critical disposition pathways of statins to assess drug–drug interaction risk during drug development: it's not just about OATP1B1

R Elsby, C Hilgendorf, K Fenner - Clinical Pharmacology & …, 2012 - Wiley Online Library
transporters (OATP1B1, OATP1B3, and NTCP), and OAT3 on the disposition of statins, alone
or in concert with CYP… against the transporters and drug-metabolizing enzymes deemed …

Role of OATP transporters in the disposition of drugs

M Niemi - Pharmacogenomics, 2007 - Taylor & Francis
… in the pharmacogenomics of OATP1B1 have revealed that OATP transporters can play …
-metabolizing enzymes, rifampicin has been shown to increase the expression of OATP1B1 in …

HMG-CoA reductase inhibitors (statins) and their drug interactions involving CYP enzymes, P-glycoprotein and OATP transporters-an overview

R Balasubramanian, NMP Maideen - Current drug metabolism, 2021 - ingentaconnect.com
… not substrates of CYP enzymes and hence the concomitant use of CYP inhibitors or inducers
… strates of OATP1B1 transporter, and the co-prescription of inhibitors of OATP1B1 elevates …

The effects of drug metabolizing enzyme inhibitors on hepatic efflux and uptake transporters

J Cheong, JS Halladay, E Plise, JK Sodhi… - Drug metabolism …, 2017 - ingentaconnect.com
… from transporter interactions. In contrast, SKF-525A another nonselective CYP inhibitor not
… but also inhibited uptake transporter activities mediated by OATP1B1, OATP1B3 and OCT1. …

Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) Transporters in the Intestine, Liver and Kidney

ZM Zaïr, JJ Eloranta, B Stieger… - …, 2008 - Taylor & Francis
… mediated by CYP enzymes, although other enzymes, such as … are further detoxified by
enzymes via conjugation reactions, … to have an effect on OATP1B1 transporter function. Niemi et al…